Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field

Lung cancer treatment is constantly evolving due to technological advances in the delivery of radiation therapy. Adaptive radiation therapy (ART) allows for modification of a treatment plan with the goal of improving the dose distribution to the patient due to anatomic or physiologic deviations from...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huzaifa Piperdi, Daniella Portal, Shane S. Neibart, Ning J. Yue, Salma K. Jabbour, Meral Reyhan
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/c621c7d25c6840f1926fd0042a8282a2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c621c7d25c6840f1926fd0042a8282a2
record_format dspace
spelling oai:doaj.org-article:c621c7d25c6840f1926fd0042a8282a22021-12-01T11:25:53ZAdaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field2234-943X10.3389/fonc.2021.770382https://doaj.org/article/c621c7d25c6840f1926fd0042a8282a22021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.770382/fullhttps://doaj.org/toc/2234-943XLung cancer treatment is constantly evolving due to technological advances in the delivery of radiation therapy. Adaptive radiation therapy (ART) allows for modification of a treatment plan with the goal of improving the dose distribution to the patient due to anatomic or physiologic deviations from the initial simulation. The implementation of ART for lung cancer is widely varied with limited consensus on who to adapt, when to adapt, how to adapt, and what the actual benefits of adaptation are. ART for lung cancer presents significant challenges due to the nature of the moving target, tumor shrinkage, and complex dose accumulation because of plan adaptation. This article presents an overview of the current state of the field in ART for lung cancer, specifically, probing topics of: patient selection for the greatest benefit from adaptation, models which predict who and when to adapt plans, best timing for plan adaptation, optimized workflows for implementing ART including alternatives to re-simulation, the best radiation techniques for ART including magnetic resonance guided treatment, algorithms and quality assurance, and challenges and techniques for dose reconstruction. To date, the clinical workflow burden of ART is one of the major reasons limiting its widespread acceptance. However, the growing body of evidence demonstrates overwhelming support for reduced toxicity while improving tumor dose coverage by adapting plans mid-treatment, but this is offset by the limited knowledge about tumor control. Progress made in predictive modeling of on-treatment tumor shrinkage and toxicity, optimizing the timing of adaptation of the plan during the course of treatment, creating optimal workflows to minimize staffing burden, and utilizing deformable image registration represent ways the field is moving toward a more uniform implementation of ART.Huzaifa PiperdiDaniella PortalShane S. NeibartNing J. YueSalma K. JabbourSalma K. JabbourMeral ReyhanFrontiers Media S.A.articleadaptive radiation therapy (ART)adaptive planningnon-small cell lung cancersmall cell lung cancer (SCLC)lung cancerNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic adaptive radiation therapy (ART)
adaptive planning
non-small cell lung cancer
small cell lung cancer (SCLC)
lung cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle adaptive radiation therapy (ART)
adaptive planning
non-small cell lung cancer
small cell lung cancer (SCLC)
lung cancer
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Huzaifa Piperdi
Daniella Portal
Shane S. Neibart
Ning J. Yue
Salma K. Jabbour
Salma K. Jabbour
Meral Reyhan
Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
description Lung cancer treatment is constantly evolving due to technological advances in the delivery of radiation therapy. Adaptive radiation therapy (ART) allows for modification of a treatment plan with the goal of improving the dose distribution to the patient due to anatomic or physiologic deviations from the initial simulation. The implementation of ART for lung cancer is widely varied with limited consensus on who to adapt, when to adapt, how to adapt, and what the actual benefits of adaptation are. ART for lung cancer presents significant challenges due to the nature of the moving target, tumor shrinkage, and complex dose accumulation because of plan adaptation. This article presents an overview of the current state of the field in ART for lung cancer, specifically, probing topics of: patient selection for the greatest benefit from adaptation, models which predict who and when to adapt plans, best timing for plan adaptation, optimized workflows for implementing ART including alternatives to re-simulation, the best radiation techniques for ART including magnetic resonance guided treatment, algorithms and quality assurance, and challenges and techniques for dose reconstruction. To date, the clinical workflow burden of ART is one of the major reasons limiting its widespread acceptance. However, the growing body of evidence demonstrates overwhelming support for reduced toxicity while improving tumor dose coverage by adapting plans mid-treatment, but this is offset by the limited knowledge about tumor control. Progress made in predictive modeling of on-treatment tumor shrinkage and toxicity, optimizing the timing of adaptation of the plan during the course of treatment, creating optimal workflows to minimize staffing burden, and utilizing deformable image registration represent ways the field is moving toward a more uniform implementation of ART.
format article
author Huzaifa Piperdi
Daniella Portal
Shane S. Neibart
Ning J. Yue
Salma K. Jabbour
Salma K. Jabbour
Meral Reyhan
author_facet Huzaifa Piperdi
Daniella Portal
Shane S. Neibart
Ning J. Yue
Salma K. Jabbour
Salma K. Jabbour
Meral Reyhan
author_sort Huzaifa Piperdi
title Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
title_short Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
title_full Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
title_fullStr Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
title_full_unstemmed Adaptive Radiation Therapy in the Treatment of Lung Cancer: An Overview of the Current State of the Field
title_sort adaptive radiation therapy in the treatment of lung cancer: an overview of the current state of the field
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/c621c7d25c6840f1926fd0042a8282a2
work_keys_str_mv AT huzaifapiperdi adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
AT daniellaportal adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
AT shanesneibart adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
AT ningjyue adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
AT salmakjabbour adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
AT salmakjabbour adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
AT meralreyhan adaptiveradiationtherapyinthetreatmentoflungcanceranoverviewofthecurrentstateofthefield
_version_ 1718405259278155776